4-羟基壬烯醛羰基化Runx2 K176位点加速血管钙化
该研究探讨脂质过氧化产物4-HNE在血管钙化中的作用及机制。通过慢性肾脏病患者血清、冠心病患者影像遗传学分析及多种ALDH2基因修饰小鼠模型,结合原代血管平滑肌细胞实验,发现4-HNE通过直接羰基化Runx2的K176位点增强其稳定性,促进血管平滑肌细胞成骨软骨样分化与血管钙化,ALDH2可能是治疗血管钙化的潜在靶点。
要点
- 4-HNE通过羰基化Runx2 K176位点增强其稳定性,促进血管钙化。
- ALDH2敲除加速小鼠血管钙化,过表达或激活则抑制钙化。
- ALDH2 rs671突变冠心病患者冠状动脉钙化更严重。
核心结论
- 4-HNE通过直接羰基化Runx2的K176位点增加其稳定性,从而促进血管钙化。
- ALDH2可能是治疗血管钙化的潜在靶点。
研究设计与样本
- 收集慢性肾脏病患者与对照血清,检测4-HNE和8-iso-prostaglandin F2α水平。
- 对供者冠状动脉粥样硬化斑块切片行免疫染色,分析钙沉积与4-HNE。
- 招募658例接受冠状动脉CT血管造影的冠心病患者,分析冠状动脉钙化与ALDH2 rs671突变的关系。
- 使用ALDH2基因敲除、平滑肌细胞特异性ALDH2敲除、ALDH2转基因小鼠及其对照建立血管钙化模型。
- 原代小鼠主动脉平滑肌细胞和人主动脉平滑肌细胞暴露于含β-甘油磷酸盐和CaCl2的培养基,研究细胞钙化及分子机制。
主要发现
- 慢性肾脏病患者血清和模型小鼠中4-HNE水平升高,免疫染色在钙化动脉切片中检测到4-HNE。
- ALDH2敲除或平滑肌细胞特异性ALDH2敲除加速模型小鼠血管钙化,而过表达或激活则预防小鼠血管钙化及血管平滑肌细胞成骨软骨样分化。
- 冠心病患者中,ALDH2 rs671基因突变者发生更严重的冠状动脉钙化。
- 4-HNE促进小鼠主动脉平滑肌细胞和人主动脉平滑肌细胞的钙化及成骨软骨样分化。
- 4-HNE增加Runx2水平,敲低Runx2后4-HNE促血管平滑肌细胞钙化作用被消除。
临床怎么用
- ALDH2 rs671突变冠心病患者可能需更关注冠状动脉钙化进展。
- ALDH2激活或过表达在动物模型中预防血管钙化,提示其作为治疗靶点的潜力。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vascular calcification, which is characterized by calcium deposition in arterial walls and the osteochondrogenic differentiation of vascular smooth muscle cells, is an actively regulated process that involves complex mechanisms. Vascular calcification is associated with increased cardiovascular adverse events. The role of 4-hydroxynonenal (4-HNE), which is the most abundant stable product of lipid peroxidation, in vascular calcification has been poorly investigated. METHODS: Serum was collected from patients with chronic kidney disease and controls, and the levels of 4-HNE and 8-iso-prostaglandin F2α were measured. Sections of coronary atherosclerotic plaques from donors were immunostained to analyze calcium deposition and 4-HNE. A total of 658 patients with coronary artery disease who received coronary computed tomography angiography were recruited to analyze the relationship between coronary calcification and the rs671 mutation in aldehyde dehydrogenase 2 (ALDH2). ALDH2 knockout (ALDH2-/-) mice, smooth muscle cell-specific ALDH2 knockout mice, ALDH2 transgenic mice, and their controls were used to establish vascular calcification models. Primary mouse aortic smooth muscle cells and human aortic smooth muscle cells were exposed to medium containing β-glycerophosphate and CaCl2 to investigate cell calcification and the underlying molecular mechanisms. RESULTS: Elevated 4-HNE levels were observed in the serum of patients with chronic kidney disease and model mice and were detected in calcified artery sections by immunostaining. ALDH2 knockout or smooth muscle cell-specific ALDH2 knockout accelerated the development of vascular calcification in model mice, whereas overexpression or activation prevented mouse vascular calcification and the osteochondrogenic differentiation of vascular smooth muscle cells. In patients with coronary artery disease, patients with ALDH2 rs671 gene mutation developed more severe coronary calcification. 4-HNE promoted calcification of both mouse aortic smooth muscle cells and human aortic smooth muscle cells and their osteochondrogenic differentiation in vitro. 4-HNE increased the level of Runx2 (runt-related transcription factor-2), and the effect of 4-HNE on promoting vascular smooth muscle cell calcification was ablated when Runx2 was knocked down. Mutation of Runx2 at lysine 176 reduced its carbonylation and eliminated the 4-HNE-induced upregulation of Runx2. CONCLUSIONS: Our results suggest that 4-HNE increases Runx2 stabilization by directly carbonylating its K176 site and promotes vascular calcification. ALDH2 might be a potential target for the treatment of vascular calcification.
引用
- Zhai X, Cao S, Wang J, et al. Carbonylation of Runx2 at K176 by 4-Hydroxynonenal Accelerates Vascular Calcification. Circulation. 2024. PMID: 38348663. doi:10.1161/CIRCULATIONAHA.123.065830
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。